SCHEMBL5567632

SCHEMBL5567632

C=C1OC(C)C(=O)OC1C

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15580578 1.00 CA1 (0.32) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL16772762 1.00 CA1 (0.32) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL16772760 1.00 CA1 (0.32) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL13469554 0.83
SCHEMBL8104271 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL15034 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL2860232 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL439067 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL15195848 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2
SCHEMBL44996 0.83 CA1 (0.41) CA1CA9MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155747-A1 Lactate Production Process NATUREWORKS LLC (US) 2018-06-07 US disclosed
WO-2017029479-A1 MULTI-BLOCK COPOLYMERS IMPERIAL INNOVATIONS LIMITED (GB) 2017-02-23 WO disclosed
US-20150152449-A1 Lactate Production Process NATUREWORKS LLC 2015-06-04 US disclosed
US-8926998-B2 Polycarbonates bearing pendant primary amines for medical applications INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-01-06 US disclosed
EP-2392570-B1 Method for manufacturing a mixture of lactide derivatives UHDE INVENTA FISCHER GMBH (DE) 2014-10-01 EP disclosed
US-20140072607-A1 POLYCARBONATES BEARING PENDANT PRIMARY AMINES FOR MEDICAL APPLICATIONS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-03-13 US disclosed
US-20130095186-A1 TEMPERATURE-SENSITIVE CARRIER FOR CARRYING A PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PREPARATION METHOD THEREOF Catholic University Industry Academic Cooperation Foundation (KR) 2013-04-18 US disclosed
US-20130095186-A1 TEMPERATURE-SENSITIVE CARRIER FOR CARRYING A PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PREPARATION METHOD THEREOF Catholic University Industry Academic Cooperation Foundation (KR) 2013-04-18 US disclosed
US-20120114615-A1 HYDROLYTICALLY DEGRADABLE POLYSACCHARIDE HYDROGELS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-05-10 US disclosed
EP-2125067-B1 POLYMER-AND POLYMER BLEND-BIOCERAMIC COMPOSITE IMPLANTABLE MEDICAL DEVICES ABBOTT CARDIOVASCULAR SYSTEMS (US) 2011-01-19 EP disclosed
EP-1144013-B1 LACTONE BEARING ABSORBABLE POLYMERS SOD CONSEILS RECH APPLIC (FR) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155747-A1 Lactate Production Process LDHA, LDHB, SORD CA1 908/4885CA9 775/4885MEN1 4470/4885
US-20130095186-A1 TEMPERATURE-SENSITIVE CARRIER FOR CARRYING A PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PREPARATION METHOD THEREOF PAICS, ATIC, SMS CA1 397/4885CA9 770/4885MEN1 3263/4885
US-20140072607-A1 POLYCARBONATES BEARING PENDANT PRIMARY AMINES FOR MEDICAL APPLICATIONS PAM, PARG, H1-2 CA1 2384/4885CA9 1468/4885MEN1 803/4885
US-20150152449-A1 Lactate Production Process LDHA, LDHB, SORD CA1 908/4885CA9 775/4885MEN1 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.